RSA Viewpoints

It’s Time to Change the Game

Amongst the many panel discussions that took place at the Bio Integrates event on the 17th of May, the headline session for me was...

BioTech’s Ultimate Challenge

Our Senior Consultant Kerry Hillier attended the “Value in, Value Out,” panel discussion at Bio Integrates on 17th May. The session was facilitated by...

Inspiring Leaders | Johan Luthman

Johan Luthman is Executive Vice President and Head of Research & Development at Lundbeck, a global pharmaceutical company specialising in brain diseases. With more...

A Lesson in Culture

On the 17th of May, I attended the Bio Integrates event – hosted by Life Science Integrates – at the Leonardo Royal Hotel in...

Inspiring Leaders | Christian Joergensen

Christian Joergensen has been a CEO and member of executive management groups in several international high-performance companies. He has also been Chairman of the...

Parkinson’s Disease Awareness Day

Monday 11th April marks World Parkinson’s Disease Day: a day focused on raising awareness of a debilitating disease that often destroy lives. When I...

Inspiring Leaders | Riccardo Palmisano

Riccardo Palmisano is the president of Assobiotec, the Italian Association for the Development of Biotechnology. After graduating with a degree in medicine, Riccardo moved...

Inspiring Leaders | Jean-Luc Butel

Jean Luc Butel is an international executive with over thirty years’ experience in the global healthcare industry.  He has worked solely for US Fortune...

Inspiring Leaders | Virginie Buggia-Prevot

Following a PhD in neurobiology and a post doc at the University of Chicago, Virginie Buggia-Prevot joined MD Anderson’s Neurodegeneration Consortium, managing strategic alliances...

Inspiring Leaders | Charlotte Casebourne

Charlotte Casebourne is the co-founder and CEO of Theolytics, a company that quickly develops oncolytic (cancer-killing) viruses. Since spinning out of the University of...

Inspiring Leaders | Jackie Hunter

Jackie Hunter, PhD DSc CBE FBPharmacolS FMedSci, is a Board Director of BenevolentAI, which is applying its AI technology across the whole of Pharma...

Inspiring Leaders | Dr. Niven R. Narain

Dr. Niven R. Narain is Co-Founder, President & CEO of Berg, a Boston-based biopharma driving next generation drug and diagnostic development by combining patient-driven...

Inspiring Leaders | Swee Yeok CHU

With over 30 years of success in venture, growth and late-stage financing as well as private equity and fund investments, Swee Yeok Chu is...

Inspiring Leaders | Steve Harbin

Steve Harbin believes it takes good science, good people and good business to develop and grow a leading biotech. He joined Oncorus Inc. as...

Inspiring Leaders | Prof. Helga Rübsamen-Schaeff

A chemist by training, Professor Helga Rübsamen-Schaeff started her career as Scientific and Executive Director of an academic institution, the Chemotherapeutical Research Institute Georg-Speyer-Haus...

Inspiring Leaders | Michelle Tempest

Our next featured Inspiring Leader is the amazing Michelle Tempest, Partner at Candesic and author of ‘Big Brain Revolution: Artificial Intelligence Spy or Saviour?‘...

Inspiring Leaders | Angela Hildreth

Our next story in the Inspiring Leaders series comes from the phenomenal Angela Hildreth, Finance Director and Chief Operating Officer at Futura Medical. We...

Inspiring Leaders | Shiva Dustdar

We were honoured to speak to Shiva Dustdar who is Head of Division, Innovation Finance Advisory for the European Investment Bank. In this blog...

Unleashing The Power of Interims

Businesses are dynamic; they grow, contract, fail and succeed. Research has firmly established that this process is vital to productivity and sustained growth in...

RSA Talent Talks debut Podcast

We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...

The Human Factor in MedTech

The medtech industry is growing rapidly, with projected compound annual growth rates of 5.6% worldwide from 2017, reaching $595 billion by 2024. This raises the...

Anyone for T?

The increasing demand for highly specialised skill sets in drug development Do employers prefer specialists or generalists? While many would answer ‘it depends’, the...

RSA Viewpoint | 2019 Outlook

Smart thinking can overcome talent shortages in 2019 As we leave 2018, we’re living through fast growing surge of change, to which the Life...

AMRC | HR Benchmarking Report

In May 2018, the Association of Medical Research Charities (AMRC) circulated a survey of 50 questions to member charity CEOs and formal representatives. The...

Brexit’s Uncertainty Principle

While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...

Outlook: Medtech 2030

Having travelled in Europe in the last few weeks meeting clients and candidates, I wanted to share some reflections with you linked to one...

Where are all the medtech medics?

For many years now there has been a clear path for medical professionals who move from education to working in the pharmaceutical industry, both...

Lateral thinking for oncology leadership

The rapid growth in immuno-oncology therapeutics is causing talent headaches for the pharma industry Patients are already benefitting from pharma’s success in developing new...

RSA Viewpoint | The Successful Leader

There’s no doubt the leader’s job is becoming increasingly difficult in today’s environment. We’re experiencing unprecedented levels of change – societal, political, economic and...

Building talent and saving lives

London was the setting last week for the 25th Annual Meeting of the International Society for Cellular Therapy. The huge increase of clinical trials...

A Report from BIO-Europe Spring 2017

The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...

Report from J.P. Morgan 2017

So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...

Shaping up for growth in a world of change

The 34th FT Global Pharmaceutical and Biotechnology Conference brought together life science and pharma companies as well as emerging new players. Discussions centered on industry challenges,...

Change for the better

Talent is more global now than ever. In light of the recent Brexit vote and the fact that demand for talent in Europe is...

What next for EU and UK biotech boards?

In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...

Future Talent Hard Data and Soft Skills

Imagine 1000 HR professionals in a theatre. Everyone with work and people challenges, mobile phones and email to answer. Cue Martine Wright, a survivor...

Biotech & Money, London, 2016

The meeting focused on harnessing the value of innovation and new models for collaboration. No small task. It had a strong UK focus but...

What Makes Successful Biotech Boards?

This report looks forensically at correlations between company performance and Board composition. From this we draw out lessons that can be learned from the...

Report from JP Morgan 2016

The ‘Salmon Run’ of the Life Sciences is over for another year. Here are some take home messages. Public funding is uncertain but institutional investor coffers are full The withdrawal...

Avoid firing through better hiring

Luke Johnson, the serial entrepreneur and investor made a critical insight in his recent column in the Sunday Times. He wrote about how difficult and costly it...

It’s a seller’s market

How the world has changed Twelve months’ ago the life sciences executive search market was driven by employers, the market was recovering from three...

The Human Remains

With my legal training, business career and over 15 years in senior level executive search my ears have been tuned to listen to the...

Talent acquisition and M&As

Chris Molloy, CEO at RSA, believes that only by placing talent acquisition at the heart of mergers and acquisitions (M&As) can the maximum value...

Board Level

Nick Stephens examines the power of the board. The sun is shining, investors are investing and the life sciences sector is going through an...

Talent Pool

The pace of change and the many requirements affecting all those working in the life sciences industry have never been higher, particularly with regards...

The role and impact of HR in M&A

Much has been said and written about the objectives and success rate of mergers and acquisitions. A 2000 KPMG study showed that, across industries,...

Developing a long term talent plan

In today’s highly competitive Life Sciences industry, a critical success factor for executives is to fully understand the talent they have within their business...

Shifting Sands

Although the contract services sector has been recovering over the last few years, contract manufacturing organisations haven’t been so lucky. The answer is far...

Betting Big

As China looks to become a leader in the pharma scene, what should be done differently to create an R&D site culture that incentivises...

Betting big on research in China

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – only to have been...

Busting the international recruitment myths

International recruitment involves searching, hiring and deploying people to another location for a position where they can perform effectively. It is usually a complex...

Helping Archimedes Pharma to grow

Today’s Financial Times features a supplement dedicated to the issue of working in interim management. The supplement features a specific case study, written by...